207 related articles for article (PubMed ID: 30160576)
1. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease.
Burke SL; Hu T; Spadola CE; Burgess A; Li T; Cadet T
J Aging Health; 2019 Feb; 31(2):322-342. PubMed ID: 30160576
[TBL] [Abstract][Full Text] [Related]
2. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.
Burke SL; Hu T; Spadola CE; Li T; Naseh M; Burgess A; Cadet T
Sleep Med; 2018 Dec; 52():168-176. PubMed ID: 30359892
[TBL] [Abstract][Full Text] [Related]
3. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.
Burke SL; Maramaldi P; Cadet T; Kukull W
Int Psychogeriatr; 2016 Sep; 28(9):1409-24. PubMed ID: 27020605
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
5. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
Blackman J; Love S; Sinclair L; Cain R; Coulthard E
Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
[TBL] [Abstract][Full Text] [Related]
6. The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
Kim H; Levine A; Cohen D; Gehrman P; Zhu X; Devanand DP; Lee S; Goldberg TE;
J Alzheimers Dis; 2022; 87(4):1567-1580. PubMed ID: 35491776
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.
Koo KYG; Schweizer TA; Fischer CE; Munoz DG
Curr Alzheimer Res; 2019; 16(3):243-250. PubMed ID: 30605058
[TBL] [Abstract][Full Text] [Related]
8. The Relationship Between Sleep Disturbance and Apolipoprotein E ε4 in Adults With Mild Cognitive Impairment and Alzheimer's Disease Dementia: An Integrative Review.
Wei W; Wang K; Shi J; Li Z
Biol Res Nurs; 2022 Jul; 24(3):327-337. PubMed ID: 35439097
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
10. Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E.
Burke SL; Maramaldi P; Cadet T; Kukull W
Int J Geriatr Psychiatry; 2018 Jan; 33(1):200-211. PubMed ID: 28560728
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial risk factors and Alzheimer's disease: the associative effect of depression, sleep disturbance, and anxiety.
Burke SL; Cadet T; Alcide A; O'Driscoll J; Maramaldi P
Aging Ment Health; 2018 Dec; 22(12):1577-1584. PubMed ID: 29077487
[TBL] [Abstract][Full Text] [Related]
12. Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.
Yesavage JA; Friedman L; Kraemer H; Tinklenberg JR; Salehi A; Noda A; Taylor JL; O'Hara R; Murphy G
J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):20-4. PubMed ID: 15018693
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
[TBL] [Abstract][Full Text] [Related]
14. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
Ren D; Lopez OL; Lingler JH; Conley Y
J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
[TBL] [Abstract][Full Text] [Related]
15. Sleep disturbance: an emerging opportunity for Alzheimer's disease prevention?
Spira AP; Gottesman RF
Int Psychogeriatr; 2017 Apr; 29(4):529-531. PubMed ID: 27938445
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
17. Examination of race and gender differences in predictors of neuropsychological decline and development of Alzheimer's disease.
Johnson EEH; Alexander C; Lee GJ; Angers K; Ndiaye D; Suhr J
Clin Neuropsychol; 2022 Feb; 36(2):327-352. PubMed ID: 34218735
[No Abstract] [Full Text] [Related]
18. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
Yin Y; Liu Y; Pan X; Chen R; Li P; Wu HJ; Zhao ZQ; Li YP; Huang LQ; Zhuang JH; Zhao ZX
PLoS One; 2016; 11(3):e0149945. PubMed ID: 26937653
[TBL] [Abstract][Full Text] [Related]
20. The Association Between the Use of Zolpidem and the Risk of Alzheimer's Disease Among Older People.
Cheng HT; Lin FJ; Erickson SR; Hong JL; Wu CH
J Am Geriatr Soc; 2017 Nov; 65(11):2488-2495. PubMed ID: 28884784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
